Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
48
MOLN Quote, Financials, Valuation and Earnings
Last price:
$5.43
Seasonality move
:
-0.31%
Day range:
$5.26 - $5.46
52-week range:
$3.32 - $12.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
26.52x
P/B ratio:
1.22x
Volume:
4K
Avg. volume:
18.4K
1-year change:
28.5%
Market cap:
$201.1M
Revenue:
$7.8M
EPS (TTM):
-$2.14
Earnings Data
Next earnings date for MOLN
Mar 07
2025
Most recent earnings per share
-$0.57
Beat by $0.06
(Sep 30/2024)
Consensus Estimate
-$0.63
(Sep 30/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MOLN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/07/2025 | Q4 | -- | -- | -- | -$0.45 | -- |
| 09/30/2024 | Q3 | -- | $787.5K | -$0.57 | -$0.63 | $0.06 |
| 08/26/2024 | Q2 | -- | $1.7M | -$0.51 | -- | -- |
| 03/31/2024 | Q1 | $1.4M | $3.1M | -$0.39 | -- | -- |
| 03/15/2024 | Q4 | -- | $1.2M | -$0.68 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.40 | -- | -- |
| 08/25/2023 | Q2 | -- | -- | -$0.55 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.49 | -- | -- |
| 03/09/2023 | Q4 | -- | -- | -$0.56 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.42 | -- | -- |
| 08/25/2022 | Q2 | -- | -- | -$0.15 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | $5.00 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.61 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.41 | -- | -- |
| 08/26/2021 | Q2 | -- | -- | -$0.61 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.63 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.85 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.65 | -- | -- |
Molecular Partners AG Earnings Questions
-
How Much did Molecular Partners AG Generate in Revenue Last Quarter?
Molecular Partners AG reported $787.5K worth of top line sales in its most recent quarter.
-
Did Molecular Partners AG Beat Earnings Last Quarter?
Molecular Partners AG announced earnings per share of -$0.57 which represents a beat of analyst forecast a -$0.63 per share.
-
Is Molecular Partners AG Profitable?
Molecular Partners AG reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Molecular Partners AG EPS Next Year?
Molecular Partners AG's earnings are forecast to decrease from -$2.10 per share to -$1.81 per share next year representing a decrease of -7.58%.
-
When is Molecular Partners AG's Earnings Date?
Molecular Partners AG's next earnings date is March 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
57
NARI alert for Jan 8
Inari Medical [NARI] is down 0.11% over the past day.
Buy
69
UNF alert for Jan 8
UniFirst [UNF] is up 3.14% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 9.46% over the past day.
